Prevalence survey and management of mutraashmari (Urolithiasis)

A survey study of prevalence on mutraashmari and evaluate the efficacy of Pashanbhedadi Kwath in the management of mutraashmari (Urolithiasis) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057297

Enrollment

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N210- Calculus in bladder Health Condition 2: N202- Calculus of kidney with calculus of ureter

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Renal and Bladder stone size 5-15mm 2. Ureteric stone size 5-8mm 3. Primary Stone 4. Radiographic and USG evidence of the stone

Exclusion criteria

Exclusion criteria: 1. Renal failure 2. Gross Hydronephrosis 3. Cases which requires surgical intervention. 4. Severe Haematuria. 5. Retention of Urine 6. Renal and Bladder stone size >15 mm 7. Ureteric stone size > 8 mm 8. Fever 9. Patient suffering from major systemic illness necessitating long term treatment. 10. H/o hypersensitivity to any drug. 11. Patients who are not willing to give consent for clinical trial.

Design outcomes

Primary

Measure	Time frame
Improvement in laboratory investigation of UrolithiasisTimepoint: Till 56 Days from the day of enrollment	—

Secondary

Measure	Time frame
Improvement in sign & symptoms of urolithiasis & improve quality of life of the patients.Timepoint: after 14 day,28 day,42 Day from the day of enrollment	—

Countries

India

Contacts

Public ContactDr Rahul Kumar

UPGIAS&R, Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur

ayurvishnu@gmail.com7742042974

Outcome results